Literature DB >> 3164672

Effect of new quinolones on drug-metabolizing enzyme system of rat hepatic microsomes.

O Okazaki1, T Kurata, H Tachizawa.   

Abstract

Effects of repeated oral administration of new quinolones, ofloxacin, enoxacin and norfloxacin, once daily for 7 days, on the drug-metabolizing enzyme system of rat hepatic microsomes were studied in comparison with that of phenobarbital, a potent inducer of cytochromes P-450. Treatment of phenobarbital at the oral dose of 120 mg/kg induced significant increases in the contents of cytochrome P-450, cytochrome b5 and NADPH-cytochrome P-450 reductase and in the activity of ethoxycoumarin O-deethylase, and significant decreases in the activities of benzphetamine N-demethylase and aniline hydroxylase. However, ofloxacin, enoxacin and norfloxacin at the oral dose levels of 80 and 320 mg/kg showed no significant effect on the content of each constituent of the drug-metabolizing enzyme system, and the three enzyme activities. Thus, it is concluded that new quinolones including ofloxacin have no ability to induce a cytochrome-P-450-dependent monooxygenase system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164672     DOI: 10.1159/000238562

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  3 in total

1.  Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman.

Authors:  Luca Gallelli; Serena Del Negro; Saverio Naty; Manuela Colosimo; Rosario Maselli; Giovambattista De Sarro
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 2.  Side-effects of quinolones: comparisons between quinolones and other antibiotics.

Authors:  S R Norrby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

3.  Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.

Authors:  Y Niki; K Itokawa; O Okazaki
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.